Ando, K., Kishino, Y., Homma, T., Kusumoto, S., Yamaoka, T., Tanaka, A., . . . Sagara, H. (2020). Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. Cancers (Basel).

Ando, Koichi, Yasunari Kishino, Tetsuya Homma, Sojiro Kusumoto, Toshimitsu Yamaoka, Akihiko Tanaka, Tohru Ohmori, Tsukasa Ohnishi, and Hironori Sagara. "Nivolumab Plus Ipilimumab Versus Existing Immunotherapies in Patients With PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis." Cancers (Basel) 2020.

Ando, Koichi, et al. "Nivolumab Plus Ipilimumab Versus Existing Immunotherapies in Patients With PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis." Cancers (Basel) 2020.